FT Partners Served as Financial Advisor to AML Analytics on its Strategic Growth Investment from Covalent Equity Partners
Overview of Transaction
- On October 26, 2026, AML Analytics (AMLA) announced a significant growth investment from Covalent Equity Partners
- Founded in 2010 and headquartered in Salisbury, UK, AMLA is the market leader in independent testing, validation, and risk analytics for sanctions and AML/CFT controls
- AMLA is trusted by more than 50 supervisory authorities and over 1,450 financial institutions across nearly 60 countries, providing empirical ground truth to measure, tune, and verify AML systems
- Covalent is a Miami-headquartered private equity firm purpose-built for the AI era, investing in data-rich and mission-critical technology companies
Significance of Transaction
- AMLA is going through a period of rapid change, experiencing exceptional growth as a major global partnership rolls out
- Covalent’s capital and operational partnership will accelerate AMLA’s engineering roadmap, introduce next-generation testing engines and expand the Company’s global footprint
FT Partners' Role
- FT Partners served as exclusive strategic and financial advisor to AML Analytics
- This transaction underscores FT Partners’ domain expertise across the Fraud Prevention, Risk and Data Analytics space, as well as its track record generating positive outcomes for innovative FinTech companies globally